Résultats de la surrénalectomie unilatérale pour hyperplasie macronodulaire bilatérale des surrénales

A. Gryn(Hôpital Rangueil), É. Huyghe(Université Toulouse III - Paul Sabatier), Delphine Vezzosi(Université Toulouse III - Paul Sabatier), M. Thoulouzan(Hôpital Rangueil), G. Crenn(Hôpital Rangueil), M. Soulié(Hôpital Rangueil), A. Bennet, P. Rischmann(Hospices Civils de Lyon), Philippe Caron(Hôpital Larrey)
The French Journal of Urology
October 29, 2013
10.1016/j.purol.2013.08.105
Cited by 0

Related Papers

Constitutive Activation of PKA Catalytic Subunit in Adrenal Cushing's Syndrome
|New England Journal of Medicine|2014|434
Ketoconazole in Cushing's Disease: Is It Worth a Try?
|The Journal of Clinical Endocrinology & Metabolism|2014|288
Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study
|Annals of Oncology|2015|257
Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses
|European Urology|2020|246
Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old
|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2015|227